相关实验视频
Updated: Sep 20, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.5K
PROS1-MERTK轴驱动瘤微环境 交叉和进展在乳腺甲状腺小瘤
Wenqian Zhang1, Ye Zhang2, Zhu Liu1
1Department of Head and Neck Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, 110042, China.
概括
研究人员确定了PROS1-MERTK信号通路是乳头甲状腺小癌 (PTMC) 进展的关键驱动因素. 这一发现为治疗侵袭性甲状腺癌的治疗提供了潜在的新点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 乳头甲状腺癌 (PTC) 的发病率正在上升,乳头甲状腺小癌 (PTMC) 占病例的一半以上.
- 虽然许多PTMC是惰的,但有些进展,需要生物标志物来进行风险分层.
研究的目的:
- 识别生物标志物和理解驱动PTMC进展的机制.
- 在PTC进展中描述细胞生态系统和细胞间通信.
主要方法:
- 在手术组织样本上单细胞RNA测序和空间转录组学.
- 在体内和体外实验验证.
主要成果:
- PTMC的进展涉及多方向的进化模式和改变的细胞间通信.
- PROS1-MERTK信号轴被认为是PTMC进展的关键.
- NFYB和FOXP2激活纤维细胞中的PROS1转录,通过MERTK/WNT/TGF-β信号促进进展.
结论:
- PROS1/MERTK轴是瘤微环境中的PTMC进展的关键调节器.
- 针对PROS1/MERTK轴可能为攻击性PTMC提供治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K

